Reuters logo
Prestige Brands to buy Insight Pharmaceuticals for $750 mln
April 25, 2014 / 11:01 AM / 4 years ago

Prestige Brands to buy Insight Pharmaceuticals for $750 mln

April 25 (Reuters) - Prestige Brands Holdings Inc, a marketer and distributor of healthcare and cleaning products, said it would buy rival Insight Pharmaceuticals Corp for $750 million in cash to expand its feminine care products range.

As part of the deal, Prestige will acquire tax attributes with a present value of about $100 million, the company said in a statement.

Insight Pharmaceuticals, known for the Monistat brand of over-the-counter yeast infection treatment, also makes home pregnancy test products. (Reporting by Maria Ajit Thomas in Bangalore; Editing by Savio D‘Souza)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below